Cicalese et al. reported that breast cancer stem cells derived from ERBB2/HER2 transgenic mice exhibited an increased frequency of symmetric self-renewing cell divisions and implicated p53 is a master regulator of this process [40]. Here, ERBB2 is linked to breast carcinoma.